期刊
THORAX
卷 68, 期 4, 页码 391-393出版社
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2012-202376
关键词
-
资金
- Bayer PLC
- Sanofi Aventis
- GlaxoSmithKline
- Pfizer
- Novartis
The National Institute for Health and Clinical Excellence recently published a clinical guideline on the management of venous thromboembolic disease and thrombophilia testing. Several stand-out recommendations are made which may be practice changing for many physicians, such as catheter-directed thrombolysis for ilio-femoral deep venous thrombosis, routine cancer screening and extended duration of anticoagulation for unprovoked events. In this article, we summarise the key points of the guideline and discuss remaining areas of controversy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据